Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Debanjan Kundu
Observed name:
Kundu, Debanjan
Institution:
SRM Institute of Science and Technology
Observed institutions:
Georgia Institute of Technology,
SRM Institute of Science and Technology,
Indian Institute of Technology BHU
ORCID:
0000-0002-8408-2175
Observed ORCID:
0000-0002-8408-2175
OpenAlex ID:
A5039458965
Identification of new anti-nCoV drug chemical compounds from Indian spices exploiting SARS-CoV-2 main protease as target
2020
·
Umesh
, Debanjan Kundu
, et al.
·
Journal of Biomolecular Structure and Dynamics
·
195
Advances in protein misfolding, amyloidosis and its correlation with human diseases
2020
·
Debanjan Kundu
, Kumari Prerna
, et al.
·
3 Biotech
·
42
Potential alternatives to current cholinesterase inhibitors: anin silicodrug repurposing approach
2021
·
Debanjan Kundu
, Vikash Kumar Dubey
·
Drug Development and Industrial Pharmacy
·
31
Study of the Correlation between Total Lipid Profile and Glycosylated Hemoglobin Among the Indigenous Population of Guwahati
2017
·
Debanjan Kundu
, Moushumi Saikia
, et al.
·
SSR Institute of International Journal of Life Sciences
·
26
Purines and Pyrimidines: Metabolism, Function and Potential as Therapeutic Options in Neurodegenerative Diseases
2020
·
Debanjan Kundu
, Vikash Kumar Dubey
·
Current Protein and Peptide Science
·
24
Interaction of selected biomolecules and metabolites with amyloidogenic proteins
2020
·
Debanjan Kundu
, Umesh
, et al.
·
Journal of Biomolecular Structure and Dynamics
·
21
Perspectives on evolutionary and functional importance of intrinsically disordered proteins
2022
·
Tanuj Handa
, Debanjan Kundu
, et al.
·
International Journal of Biological Macromolecules
·
18
Drugs repurposing against SARS-CoV2 and the new variant B.1.1.7 (alpha strain) targeting the spike protein: molecular docking and simulation studies
2021
·
Monu Pande
, Debanjan Kundu
, et al.
·
Heliyon
·
17
Distinct Interactions of Cannabinol and Its Cytochrome P450-Generated Metabolites with Receptors and Sensory Neurons
2025
·
Debanjan Kundu
, Luca Franchini
, et al.
·
Journal of Medicinal Chemistry
·
12
PDF
Vitamin C and Vitamin D3 show strong binding with the amyloidogenic region of G555F mutant of Fibrinogen A alpha-chain associated with renal amyloidosis: proposed possible therapeutic intervention
2021
·
Monu Pande
, Debanjan Kundu
, et al.
·
Molecular Diversity
·
11
Integrated computational and experimental approach for novel anti-leishmanial molecules by targeting Dephospho-coenzyme A kinase
2023
·
Naveena Menpadi
, Jay Prakash
, et al.
·
International Journal of Biological Macromolecules
·
5
Folding and stability of recombinant azoreductase enzyme from Chromobacterium violaceum
2019
·
Kamalesh Verma
, Debanjan Kundu
, et al.
·
Enzyme and Microbial Technology
·
4
Selective vitamins as potential options for dietary therapeutic interventions: In silico and In vitro insights from mutant C terminal fragment of FGA
2023
·
Monu Pande
, Debanjan Kundu
, et al.
·
The Journal of Steroid Biochemistry and Molecular Biology
·
3
Hospital Acquired Urinary Tract Infection: An Epidemiological Study Carried Out in A Tertiary Care Hospital of North East India
2017
·
Debanjan Kundu
, Tulika Paul
, et al.
·
SSR Institute of International Journal of Life Sciences
·
3
Drug repurposing approach for identifying Pfmrk inhibitors as potential antimalarial agents: An in silico analysis
2023
·
Abhishek Sahu
, Tanuj Handa
, et al.
·
INNOSC Theranostics and Pharmacological Sciences
·
2
Therapeutic Targeting of Collagen Biosynthetic Enzymes in Cancer
2026
·
Srejani Koley
, Debanjan Kundu
, et al.
·
Journal of Current Oncology
Show more works
View as search
Works count:
18
Citation count:
416
H-index:
10
I10-index:
10
Year
Topic
Type